Intracytoplasmic morphologically selected sperm injection versus conventional intracytoplasmic sperm injection: A randomized controlled trial

Giovanni Battista La Sala, Alessia Nicoli, Eleonora Fornaciari, Angela Falbo, Ilaria Rondini, Daria Morini, Barbara Valli, Maria Teresa Villani, Stefano Palomba

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Intracytoplasmic morphologically selected sperm injection (IMSI) is still proposed and employed in the clinical practice to improve the reproductive outcome in infertile couples scheduled for conventional intracytoplasmic sperm injection (cICSI). The aim of the current randomized controlled trial (RCT) was to test the hypothesis that IMSI gives a better live birth delivery rate than cICSI. Methods: Infertile couples scheduled for their first cICSI cycle for male factor were allocated using a simple randomization procedure. All available biological and clinical data were recorded and analyzed in a triple-blind fashion. Results: Our final analysis involved the first 121 patients (48 and 73 subjects for IMSI and cICSI arm, respectively) because the trial was stopped prematurely on the advice of the data safety and monitoring Committee because of concerns about IMSI efficacy at the first interim analysis. No significant difference between arms was detected in rates of clinical pregnancy per embryo transferred [11/34 (32.3 %) vs. 15/64 (23.4 %); odds ratio (OR) 1.56, 95 % (confidence interval) CI 0.62-3.93, P = 0.343] and of live birth delivery [9/48 (18.8 %) vs. 11/73 (15.1 %); OR 1.30, 95%CI 0.49-3.42, P = 0.594). Conclusion: Current data did not support the routine use of IMSI in the clinical practice for improving cICSI results in unselected infertile couples with male factor.

Original languageEnglish
Article number97
JournalReproductive Biology and Endocrinology
Volume13
Issue number1
DOIs
Publication statusPublished - Aug 27 2015

Fingerprint

Intracytoplasmic Sperm Injections
Spermatozoa
Randomized Controlled Trials
Injections
Live Birth
Clinical Trials Data Monitoring Committees
Odds Ratio
Birth Rate
Pregnancy Rate
Random Allocation
Embryonic Structures
Confidence Intervals
Safety

Keywords

  • ICSI
  • IMSI
  • Intracytoplasmic morphologically selected sperm injection
  • Intracytoplasmic sperm injection
  • MSOME
  • RCT

ASJC Scopus subject areas

  • Developmental Biology
  • Endocrinology
  • Reproductive Medicine

Cite this

Intracytoplasmic morphologically selected sperm injection versus conventional intracytoplasmic sperm injection : A randomized controlled trial. / La Sala, Giovanni Battista; Nicoli, Alessia; Fornaciari, Eleonora; Falbo, Angela; Rondini, Ilaria; Morini, Daria; Valli, Barbara; Villani, Maria Teresa; Palomba, Stefano.

In: Reproductive Biology and Endocrinology, Vol. 13, No. 1, 97, 27.08.2015.

Research output: Contribution to journalArticle

La Sala, Giovanni Battista ; Nicoli, Alessia ; Fornaciari, Eleonora ; Falbo, Angela ; Rondini, Ilaria ; Morini, Daria ; Valli, Barbara ; Villani, Maria Teresa ; Palomba, Stefano. / Intracytoplasmic morphologically selected sperm injection versus conventional intracytoplasmic sperm injection : A randomized controlled trial. In: Reproductive Biology and Endocrinology. 2015 ; Vol. 13, No. 1.
@article{1e9149db4e8a4e2597cd6c716cab7880,
title = "Intracytoplasmic morphologically selected sperm injection versus conventional intracytoplasmic sperm injection: A randomized controlled trial",
abstract = "Background: Intracytoplasmic morphologically selected sperm injection (IMSI) is still proposed and employed in the clinical practice to improve the reproductive outcome in infertile couples scheduled for conventional intracytoplasmic sperm injection (cICSI). The aim of the current randomized controlled trial (RCT) was to test the hypothesis that IMSI gives a better live birth delivery rate than cICSI. Methods: Infertile couples scheduled for their first cICSI cycle for male factor were allocated using a simple randomization procedure. All available biological and clinical data were recorded and analyzed in a triple-blind fashion. Results: Our final analysis involved the first 121 patients (48 and 73 subjects for IMSI and cICSI arm, respectively) because the trial was stopped prematurely on the advice of the data safety and monitoring Committee because of concerns about IMSI efficacy at the first interim analysis. No significant difference between arms was detected in rates of clinical pregnancy per embryo transferred [11/34 (32.3 {\%}) vs. 15/64 (23.4 {\%}); odds ratio (OR) 1.56, 95 {\%} (confidence interval) CI 0.62-3.93, P = 0.343] and of live birth delivery [9/48 (18.8 {\%}) vs. 11/73 (15.1 {\%}); OR 1.30, 95{\%}CI 0.49-3.42, P = 0.594). Conclusion: Current data did not support the routine use of IMSI in the clinical practice for improving cICSI results in unselected infertile couples with male factor.",
keywords = "ICSI, IMSI, Intracytoplasmic morphologically selected sperm injection, Intracytoplasmic sperm injection, MSOME, RCT",
author = "{La Sala}, {Giovanni Battista} and Alessia Nicoli and Eleonora Fornaciari and Angela Falbo and Ilaria Rondini and Daria Morini and Barbara Valli and Villani, {Maria Teresa} and Stefano Palomba",
year = "2015",
month = "8",
day = "27",
doi = "10.1186/s12958-015-0096-y",
language = "English",
volume = "13",
journal = "Reproductive Biology and Endocrinology",
issn = "1477-7827",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Intracytoplasmic morphologically selected sperm injection versus conventional intracytoplasmic sperm injection

T2 - A randomized controlled trial

AU - La Sala, Giovanni Battista

AU - Nicoli, Alessia

AU - Fornaciari, Eleonora

AU - Falbo, Angela

AU - Rondini, Ilaria

AU - Morini, Daria

AU - Valli, Barbara

AU - Villani, Maria Teresa

AU - Palomba, Stefano

PY - 2015/8/27

Y1 - 2015/8/27

N2 - Background: Intracytoplasmic morphologically selected sperm injection (IMSI) is still proposed and employed in the clinical practice to improve the reproductive outcome in infertile couples scheduled for conventional intracytoplasmic sperm injection (cICSI). The aim of the current randomized controlled trial (RCT) was to test the hypothesis that IMSI gives a better live birth delivery rate than cICSI. Methods: Infertile couples scheduled for their first cICSI cycle for male factor were allocated using a simple randomization procedure. All available biological and clinical data were recorded and analyzed in a triple-blind fashion. Results: Our final analysis involved the first 121 patients (48 and 73 subjects for IMSI and cICSI arm, respectively) because the trial was stopped prematurely on the advice of the data safety and monitoring Committee because of concerns about IMSI efficacy at the first interim analysis. No significant difference between arms was detected in rates of clinical pregnancy per embryo transferred [11/34 (32.3 %) vs. 15/64 (23.4 %); odds ratio (OR) 1.56, 95 % (confidence interval) CI 0.62-3.93, P = 0.343] and of live birth delivery [9/48 (18.8 %) vs. 11/73 (15.1 %); OR 1.30, 95%CI 0.49-3.42, P = 0.594). Conclusion: Current data did not support the routine use of IMSI in the clinical practice for improving cICSI results in unselected infertile couples with male factor.

AB - Background: Intracytoplasmic morphologically selected sperm injection (IMSI) is still proposed and employed in the clinical practice to improve the reproductive outcome in infertile couples scheduled for conventional intracytoplasmic sperm injection (cICSI). The aim of the current randomized controlled trial (RCT) was to test the hypothesis that IMSI gives a better live birth delivery rate than cICSI. Methods: Infertile couples scheduled for their first cICSI cycle for male factor were allocated using a simple randomization procedure. All available biological and clinical data were recorded and analyzed in a triple-blind fashion. Results: Our final analysis involved the first 121 patients (48 and 73 subjects for IMSI and cICSI arm, respectively) because the trial was stopped prematurely on the advice of the data safety and monitoring Committee because of concerns about IMSI efficacy at the first interim analysis. No significant difference between arms was detected in rates of clinical pregnancy per embryo transferred [11/34 (32.3 %) vs. 15/64 (23.4 %); odds ratio (OR) 1.56, 95 % (confidence interval) CI 0.62-3.93, P = 0.343] and of live birth delivery [9/48 (18.8 %) vs. 11/73 (15.1 %); OR 1.30, 95%CI 0.49-3.42, P = 0.594). Conclusion: Current data did not support the routine use of IMSI in the clinical practice for improving cICSI results in unselected infertile couples with male factor.

KW - ICSI

KW - IMSI

KW - Intracytoplasmic morphologically selected sperm injection

KW - Intracytoplasmic sperm injection

KW - MSOME

KW - RCT

UR - http://www.scopus.com/inward/record.url?scp=84940205944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940205944&partnerID=8YFLogxK

U2 - 10.1186/s12958-015-0096-y

DO - 10.1186/s12958-015-0096-y

M3 - Article

AN - SCOPUS:84940205944

VL - 13

JO - Reproductive Biology and Endocrinology

JF - Reproductive Biology and Endocrinology

SN - 1477-7827

IS - 1

M1 - 97

ER -